Experts see chance for Covid-19 vaccine approval this fall — if done right
Here is how a fast approval might play out, if all goes well — and some warning signs that normal procedure is not being followed.
Here is how a fast approval might play out, if all goes well — and some warning signs that normal procedure is not being followed.
“It is good to see this institution taking a harder stance against sloppy science and intentional data falsification that many institutes have done in the…
A Case of Tachyphylaxis After Long-Term Intravenous Racemic Ketamine for Treatment-Resistant Depression
For some, Microsoft’s deep involvement in setting standards for the use of AI in health care raises questions about “regulatory capture.”
After scouring 200 companies’ pipelines, a new biotech firm is launching with one of the most wide-ranging pipelines yet for obesity drug development.
Imagine that your favorite independent coffee shop is bought by a global chain. Your $2 cup of joe jumps to $4 overnight. That’s essentially what’s…
For some, Microsoft’s deep involvement in setting standards for the use of AI in health care raises questions about “regulatory capture.”
As lawmakers take aim at WuXi Apptec, the issue is testing the ability of BIO’s CEO to navigate a domestic policy issue that is tangled…
After a tumultuous experience on the public markets, 23andMe CEO Anne Wojcicki is moving to take the company private.
UnitedHealth executives pressured clinical staff to follow an algorithm to cut off patients’ rehab care, leading to coverage decisions that may violate Medicare regulations.